1.Experimental research of anti-inflammatory action and immunoregulation on rabbit's brain phospholipids
Er GAO ; Huazhou LI ; Qian YUE
Chinese Pharmacological Bulletin 1987;0(02):-
Rabbit's brain phospholipids (RBP) 100~200 mg ?kg-1 ip or sc showed anti-inflammatory action on four kind of acute inflammatory animal models. Cephalin and Lecithin were the effective component of antiin-flammatory action on the acute inflammatory animal model. But RBP did not show antiinflam-matory action on the chronic proliferative inflammatory model. RBP increased blood carbon particle clearance, perfaneal macrophage phagocytosis and enhanced lymphocyte proliferation,hemolysin antibody in normal and immunode-pression animal. RBP increased the cGMP content in the liver tissue of immunodepression animal, 0. 1~1 mg ?L-1 RBP promoted proliferation but 100 mg ?L-1 RBP inhibited proliferation induced by PHA in vitro on human lymphocyte.
2.Research on Protective Effect of Jiusuyu on Gastric Mucosa of Acute Alcoholism Mice
Muxiang YANG ; Wentao YU ; Huazhou XU ; Jinkuan HU ; Guoming LI ;
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(06):-
Objective: To investigate the protective effect and its mechanisms of Jiusuyu on gastric mucosa of acute alcoholism mice.Methods: Acute alcoholism mouse models were set up by intragastric administration of 56? Hongxing Erguotou wine,compared with Gehuajiecheng liquid,the effect of Jiusuyu on gastric mucosa pathological histology,SOD、MDA、NO and ET-1 of acute alcoholism mice were observed.Results: The gastric mucosa of mice in model group appeared obvious bleeding,fester and ulcer;a lot of phlegmonosis cells infiltrating could be seen below mucosa.At the same time the activity of SOD and level of NO in gastric mucosa were decreased(P
3.Preparation and immunogenicity and specificity characterization of Emodin-BSA-PVDF membrane artificial antigen
Lihua LI ; Wentai LIU ; Huazhou XU ; Guoping CHANG ; Nan WANG ; Yuxin TIAN ; Xuexin SONG ; Ziye ZHANG
Chinese Journal of Immunology 2015;(1):90-92
Objective:To study feasibility of preparing artificial antigen by membrane coated with hapten-carrier.To compare the Emodin-BSA membrane antigen immunogenicity and specificity against the liquid antigen.Methods:Emodin-BSA-PVDF membrane was prepared by the method that BSA was coated on PVDF membrane and the BSA was coupled with Emodin-couplint agent derivative.Rats were immunized by subcutaneous implantation.The immunogenicity and antibody specificity were characterized using Emodin-CA or Chrysophanol-CA or Physcion-CA membrane immunoassay. Results: The immunogenicity of Emodin-BSA coated membrane antigen was higher than Emodin-BSA liquid antigen;the specificity for three anthraquinones was almost the same(P>0.05). Conclusion:Emodin antiserum generated using Emodin-BSA coated membrane antigen has a high immunogenicity and specificity to Emodin.The results show it is feasible that membrane coated with hapten-carrier is used as artificial antigen.
4.Effects of Compound Danshen Injection on Local Angiotensin Ⅱ in Rat kidney with Unilateral Ureteral Obstruction
Qingyou XU ; Yuyong ZHAO ; Huazhou XU ; Li ZHU ; Gang CAO ; Yanhong WEI ;
Chinese Traditional Patent Medicine 1992;0(06):-
Objective:To investigate the protective effects of Compound Danshen Injection and Benazepril on rats with obstructive nephrosis.Methods:The interstitial nephritis model of rat was established by ligating unilateral ureter. The model rats were given drug Compound Danshen Injection and Benazepril, respectively. The levels of angiotensin Ⅱ (Ang Ⅱ), endothelin (ET 1) and the activity of angiotensin converting enzyme (ACE) in renal tissues were measured. Results: The level of angiotensin Ⅱ of Compound Danshen Injection group was 42.03?13.95pg/mg lower that of pathologic group (80.19?27.31pg/mg). The level of Benazepril group was 32.53?8.07pg/mg. There were significant differences among them. The measuring results of ACE and ET 1 were similiar to that of Ang Ⅱ.Conclusion: Compound Danshen Injection and Benazepril can effectively inhibit the activity of ACE and decrease the levels of Ang Ⅱ and ET 1.
5.Study on the current situation and influencing factors of nursing human resources allocation in grassroot medical institutions
Li YAN ; Wei QI ; Huazhou FANG ; Tianchun DING
Chinese Journal of Practical Nursing 2018;34(18):1423-1432
Objective To evaluate the status and influencing factors of nursing human resources allocation in grass root medical institutions in Wanzhou District of Chongqing in 12th Five-Year , and to provide reference for decision making by the relevant departments. Method A questionnaire survey was conducted among 52 grass root medical institutions in Wanzhou District of Chongqing, and the current situation and influencing factors of nursing human resources were evaluated by chi square test, rank sum test and principal component regression. Results During the period of 12th Five-Year, the nurses growth rate of grass root medical institutions in the region was 106.6%(321/301), and the ratio of bed to nurse was 1:0.27; The nursing human resources was young, the working age was low, the professional title level was low, the education level was high. The transfer rate of nurses was18.3%(114/622), the training rate to go out was 47.1%(293/622), the rate to willing training was 87%(541/622). Principal component regression analysis showed that the main factors affecting the allocation of nursing human resources were financial subsidy income, human resource expenditure, total income, business income and the total number of days occupied bed days. Conclusions The nurses human resources of the grass root medial institutions in the region increased rapidly during 12th Five-Year .However , total nursing manpower is not up to standard, the structure configuration of nurses is unreasonable, the phenomenon of the nurse job transfer is serious, the training opportunities of nurse are less, the training will of nurse is high.The financial subsidy income, human resource expenditure, total income, business income, the total number of actual occupied bed days is related to the allocation of nursing manpower. Measures should be taken to optimize the allocation of nursing manpower.
6.Effects of buzhong yiqi decoction on adriamycin induced heart failure in rats.
Na WANG ; Jianping ZHANG ; Huazhou XU ; Guiying WANG ; Li CHU
China Journal of Chinese Materia Medica 2011;36(4):508-510
OBJECTIVETo study the effects and mechanism of Buzhong Yiqi decoction on adriamycin-induced acute myocardial injury in rats.
METHOD50 rats were randomly divided to five groups: control group, heart failure group, low dose Buzhong Yiqi decoction, high dose Buzhong Yiqi decoction and captopril group. Adriamycin was injected into the latter four groups to built a model of heart failure. Then, the effects of different doses of Buzhong Yiqi decoction on hemodynamics, cardiac tissue histological changes, antioxidant capacity and apoptosis of the damaged hearts were studied.
RESULTAdriamycin led to myocardial fiber swelling and fracture, Buzhong Yiqi decoction could reduce myocardial lesions. Buzhong Yiqi decoction could also improve heart antioxidant capacity and inhibit adriamycin-induced cardiomyocyte apoptosis.
CONCLUSIONBuzhong Yiqi decoction could significantly ease adriamycin induced heart failure in rats, and the mechanism is related to anti-oxidation and inhibiting apoptosis.
Animals ; Antibiotics, Antineoplastic ; toxicity ; Doxorubicin ; toxicity ; Drugs, Chinese Herbal ; pharmacology ; Heart Failure ; chemically induced ; prevention & control ; Male ; Nitric Oxide ; biosynthesis ; Rats ; Rats, Sprague-Dawley ; Superoxide Dismutase ; blood ; Ventricular Function, Left ; drug effects
7.Herbalogical study on historical evolution of collection, processing and efficacy of Citri Exocarpium Rubrum and Citri Grandis Exocarpium.
Chu-Chu ZHONG ; Meng-Hua WU ; Pin-Hao YU ; Feng LI ; Ying ZHANG ; Zhi-Guo MA ; Chao-Jie XIE ; Hui CAO
China Journal of Chinese Materia Medica 2021;46(18):4865-4874
In ancient times, the original plants of Citri Exocarpium Rubrum and Citri Grandis Exocarpium had experienced succession and change, including tangerine(Citrus reticulata), pomelo(C. grandis), and Huazhou pomelo(C. grandis 'Tomentosa'), a specific cultivar of C. grandis produced in Huazhou, Guangdong. Before the Qing Dynasty, tangerine was the main original plant, while Huazhou pomelo came to the fore in the Qing Dynasty. In the 1950 s and 1960 s, the producing area of Huazhou pomelo was destroyed, and thus it had to be supplemented with pomelo. From then on, C. grandis 'Tomentosa' and C. grandis were both listed as the original plants of Citri Grandis Exocarpium in the Chinese Pharmacopoeia. This paper reviewed the historical evolution of the collection, processing, and efficacy of Citri Exocarpium Rubrum and Citri Grandis Exocarpium. The research showed that:(1)The harvest time of the original plants of Citri Grandis Exocarpium and Citri Grandis Exocarpium had changed from maturity to immaturity. The collection and processing of Citri Exocarpium Rubrum was first recorded in the Illustrated Classics of Materia Medica in the Song Dynasty. During the Ming and Qing Dynasties, the mesocarp of Citri Exocarpium Rubrum needed to be removed completely, and Citri Grandis Exocarpium from C. grandis 'Tomentosa' was processed into different specifications such as seven-piece, five-piece, and single piece. Furthermore, processed young fruits of Huazhou pomelo appeared.(2)Citri Exocarpium Rubrum and Citri Grandis Exocarpium were processed with carp skin for the first time in the Master Lei's Discourse on Medicinal Processing. It was suggested that carp skin might be helpful for eliminating bones stuck in throat. During the Song, Jin, and Yuan Dynasties, some other processing methods such as ba-king, stir-frying, and salt-processing appeared. Honey, soil, ginger juice, and alum were firstly used as adjuvants for the processing in the Ming and Qing Dynasties. Citri Exocarpium Rubrum was mainly prepared with salt in order to improve the effect of lowering Qi, while it was unnecessary for Citri Grandis Exocarpium from C. grandis 'Tomentosa' because of its obvious effect of lowering Qi and eliminating phlegm. The stir-frying and honey-frying methods helped reduce the strong effect of Citri Grandis Exocarpium from C. grandis 'Tomentosa'.(3)According to the application of Citri Exocarpium Rubrum and Citri Grandis Exocarpium in history, their medicinal use began in Han and Tang Dynasties, developed in Song, Jin, and Yuan Dynasties, and matured in Ming and Qing Dynasties. Citri Grandis Exocarpium from C. grandis 'Tomentosa' was originally applied in Ming and Qing Dynasties, and it still plays an important in role treating COVID-19 nowadays. Moreover, Citri Grandis Exocarpium from C. grandis had cold medicinal property, while Citri Grandis Exocarpium from C. grandis 'Tomentosa' had warm medicinal property, and thus they should not be treated the same. At present, Huazhou pomelo has a certain production scale. Therefore, it is recommended that in the next edition of Chinese Pharmacopoeia, only C. grandis 'Tomentosa' should be included as the original plant of Citri Grandis Exocarpium, and C. grandis should be deleted. The results are conducive to the further development and utilization of Citri Exocarpium Rubrum and Citri Grandis Exocarpium, and support the rational use of Citri Grandis Exocarpium and its processed products.
COVID-19
;
Citrus
;
Drugs, Chinese Herbal
;
Humans
;
Materia Medica
;
SARS-CoV-2
8.Analysis of historical origin and standardization system construction of Citri Grandis Exocarpium.
Yi-Ping YUAN ; Hua-Qiang ZHAI ; Zhao-Juan GUO ; Li-Ting KONG ; Xiao-Yu JIA ; Ning-Ning WANG ; Ying DAI ; Pin-Hao YU
China Journal of Chinese Materia Medica 2017;42(11):2214-2218
To understand the history development and changes of Citri Grandis Exocarpium and initially establish its standard system after exploring the historical origins and modern development of Citri Grandis Exocarpium. In CNKI, Wanfang database and other academic search platforms were searched for literature on Citri Grandis Exocarpium and Chinese medicine standard system; the books related to its modern cultivation techniques and processing technology were also accessed, and after combining with the actual situation analysis, the prospective design of the standard system of Citri Grandis Exocarpium was finally established with research conclusion. The earliest records of the Citri Grandis Exocarpium were documented in the Northern and Southern Dynasties, but its medicinal value was discovered in the Song Dynasty. Its drug use was developed on the basis of Jupi(orange peel) and Citri Exocarpium Rubrum. In 21st century, a number of large-scale, intensive Citri Grandis Exocarpium bases have been formed due to high price, good planting efficiency, and rapid growth of cultivation areas. The standard system includes the technical specifications of seed selection and seedling cultivation of Citri Grandis Exocarpium, technical norms of cultivation, technical specifications of fertilizing and weeding, technical specifications of irrigation and drainage, technical standard of pest and disease control, standard of medicinal materials grade, standard of processing technology of sliced pieces and the quality standard of slices, etc.
9.Effect of Modified Taohe Chengqitang on NLRP3 Inflammasomes in Rats with Diabetic Cardiomyopathy
Yanan ZHANG ; Yingjun DING ; Huazhou XU ; Ziliang LI ; Qiuju SI
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(16):59-65
ObjectiveTo investigate the effect of modified Taohe Chengqitang on NOD-like receptor protein 3 (NLRP3) inflammasome activation in rats with diabetic cardiomyopathy. MethodSPF male SD rats aged 3-4 weeks were randomly divided into a normal group and an experimental group. The rats in the experimental group were fed on a high-fat diet for 4 weeks and then received intraperitoneal injection of streptozotocin (STZ) at 35 mg·kg-1 to induce the diabetes model. The rats in the experimental group were randomly divided into model group, low- and high-dose modified Taohe Chengqitang groups (11.7 g·kg-1 and 23.4 g·kg-1), and metformin hydrochloride group (67.5 mg·kg-1) according to the fast blood glucose (FBG). The cardiac function and structure of rats were detected by ultrasonic imaging after 8 weeks of continuous intragastric administration. Blood samples from the femoral artery were collected to detect FBG, triglyceride (TC), and total cholesterol (TG) of rats. Hematoxylin-eosin (HE) staining was used to observe the pathological changes in rat myocardium. Serum levels of interleukin-1β (IL-1β) and interleukin-18 (IL-18) were determined by enzyme-linked immunosorbent assay (ELISA). The protein expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), cysteinyl aspartate-specific protease 1 (Caspase-1), and phosphorylated nuclear factor kappa-B p65 (p-NF-κB p65) in the myocardium was detected by Western blot. ResultCompared with the normal group, the model group showed increased levels of FBG, TC, and TG (P<0.01), decreased left ventricular ejection fraction (EF) and left ventricular fractional shortening (FS) (P<0.05), myocardial hypertrophy and myocardial fibrosis as revealed by HE staining, increased serum levels of 1L-1β and 1L-18 and protein expression of NLRP3, ASC, Caspase-1, and p-NF-κB p65 in myocardial tissues (P<0.01). Compared with the model group, the modified Taohe Chengqitang groups and the metformin group showed reduced levels of FBG, TC, and TG (P<0.05), restored EF and FS (P<0.05), improved pathological changes in myocardial tissues, and decreased serum levels of IL-1β and IL-18 and protein expression of NLRP3, ASC, Caspase-1, and p-NF-κB p65 in myocardial tissues (P<0.05). The improvement was more significant in the high-dose modified Taohe Chengqitang group (P<0.05). ConclusionModified Taohe Chengqitang can protect the myocardium by inhibiting the activation of NLRP3 inflammasomes.
10.Herbalogical study on historical evolution of Juhong and Huajuhong.
Meng-Hua WU ; Chu-Chu ZHONG ; Pin-Hao YU ; Feng LI ; Ying ZHANG ; Zhi-Guo MA ; Hui CAO
China Journal of Chinese Materia Medica 2021;46(3):736-744
In ancient times, there were two types of "Juhong" came from the tangerines(Citrus reticulata) and the pomelos(C. grandis and its cultivars), which corresponded to Juhong and Huajuhong recorded in the Chinese Pharmacopoeia respectively. In different periods, Juhong basically came from the same species and the same medicinal parts, but there were also some differences. This article sorted out the ancient and modern literature, under the guidance of "Succession theory of Medicinal materials varieties" and "Change theory of Medicinal materials varieties"(XIE Zong-wan), and combined with field investigation, the evolution and reasons of the original plants and medicinal parts of Juhong were analyzed. In the Han Dynasty and before, the peel of tangerines and pomelos were both used as medicine. In the Southern and Northern Dynasties, the way tangerine peel was used was dried and aged, and then "soaked in hot water and scraped off the mesocarp", which had the essence of only using exocarp as medicine of Juhong already, and its original plant was C. reticalata. In the Song Dynasty, the name of "Juhong" and its medicinal usage were recorded in book on materia medica, and the species and medicinal parts of tangerine were inherited from the previous dynasties. The way tangerine peel was used was only dried and aged without removing the mesocarp. The medicinal material obtained by the way was called Chenpi(dried and aged tangerine peel). The item "Juhong" listing as a separate medicinal material was first recorded in the Collected Discussions from Materia Medica(Bencao Huiyan) in the Ming Dynasty. In the Ming Dynasty, the Dao-di habitat of Juhong was recorded as Guangdong province in most books on materia medica, and the original plants probably were C. reticalata and C. grandis 'Tomentosa'(Huazhou pomelo, a special cultivated species of C. grandis produced in Huazhou, Guangdong, which was recorded in the Chinese Pharmacopoeia as "Huajuhong"), according to the records in the local chronicles. During the Qing Dynasty and the Republic of China, the original plants of Juhong were C. reticalata and C. grandis 'Tomentosa'. Of the two, the latter one was considered as the better. As far the medicinal part, it was still the exocarp, while the whole young fruit of C. grandis 'Tomentosa' began to be used as medicine. After the founding of The People's Republic of China, the exocarps of Citrus reticalata, C. grandis and C. grandis 'Tomentosa' were listed in the Chinese Pharmacopoeia under "Juhong". From the Northern and Southern Dynasties to the Republic of China, C. grandis exocarp was a fake of Juhong. Therefore, it was contradictory to historical records that C. grandis exocarp was listed in the Chinese Pharmacopoeia as Huajuhong. Juhong had been divided into two types as "Juhong" and "Huajuhong" since 1985. The medicinal part of Huajuhong was only the exocarp of immature and nearly mature fruits, but not the whole young fruit, the actual mainstream medicinal part of Huajuhong. The results are helpful to clarify the historical evolution of species and medicinal parts of Juhong and Huajuhong. It is suggested that in the next edition of Chinese Pharmacopoeia, only C. grandis 'Tomentosa' should be included as the original plant of Huajuhong, and C. grandis should be deleted, and the young fruit should be added in the medicinal parts besides the exocarp of immature and nearly mature fruit.
China
;
Citrus
;
Drugs, Chinese Herbal
;
Fruit
;
Materia Medica
;
Medicine, Chinese Traditional